Bjørndal Bodil, Tungland Siri Lunde, Bohov Pavol, Sydnes Magne O, Dankel Simon N, Madsen Lise, Berge Rolf K
Department of Clinical Science, University of Bergen, Bergen, Norway.
Department of Sports, Physical Activity and Food, Western Norway University of Applied Sciences, Bergen, Norway.
Liver Res. 2024 Sep 4;8(3):152-164. doi: 10.1016/j.livres.2024.09.001. eCollection 2024 Sep.
Metabolic associated fatty liver disease (MAFLD) is associated with abnormal lipid metabolism. Mitochondrial dysfunction is considered an important factor in the onset of MAFLD, whereas altered fatty acid composition has been linked to the severity of the disease. Tetradecylthioacetic acid (TTA), shown to induce mitochondrial proliferation and alter the fatty acid composition, was used to delay the accumulation of hepatic triacylglycerol. This study aimed to evaluate how impaired mitochondrial fatty acid beta-oxidation affects fatty acid composition by incorporating meldonium into a high-carbohydrate diet.
C57BL/6 mice ( = 40) were fed high-carbohydrate diets supplemented with meldonium, TTA, or a combination of meldonium and TTA for 21 days. Lipid levels were determined in liver samples, and fatty acid composition was measured in both liver and plasma samples. Additionally, desaturase and elongase activities were estimated. The hepatic activities and gene expression levels of enzymes involved in fatty acid metabolism were measured in liver samples, whereas carnitines, their precursors, and acylcarnitines were measured in plasma samples.
The meldonium-induced depletion of L-carnitine and mitochondrial fatty acid oxidation was confirmed by reduced plasma levels of L-carnitine and acylcarnitines. Principal component analyses of the hepatic fatty acid composition revealed clustering dependent on meldonium and TTA. The meldonium-induced increase in hepatic triacylglycerol levels correlated negatively with estimated activities of elongases and was associated with higher estimated activities of delta-6 desaturase (D6D; C18:4n-3/C18:3n-3 and C18:3n-6/C18:2n-6), and increased circulating levels of C18:4n-3 and C18:3n-6 (gamma-linolenic acid). TTA mitigated meldonium-induced triacylglycerol levels by 80% and attenuated the estimated D6D activities, and elongation of n-6 polyunsaturated fatty acids (PUFAs). TTA also attenuated the meldonium-mediated reduction of C24:1n-9 (nervonic acid), possibly by stimulating and increased elongation of erucic acid (C22:1n-9) to nervonic acid. The hepatic levels of nervonic acid and the estimated activity of n-6 PUFA elongation correlated negatively with the hepatic triacylglycerol levels, while the estimated activities of D6D correlated positively.
Circulating levels of gamma-linolenic acid, along with reduced estimated elongation of n-6 PUFAs and D6D desaturation activities, were associated with hepatic triacylglycerol levels.
代谢相关脂肪性肝病(MAFLD)与脂质代谢异常有关。线粒体功能障碍被认为是MAFLD发病的一个重要因素,而脂肪酸组成的改变与疾病的严重程度有关。十四烷基硫代乙酸(TTA)可诱导线粒体增殖并改变脂肪酸组成,被用于延缓肝脏三酰甘油的积累。本研究旨在通过将米多君纳入高碳水化合物饮食来评估线粒体脂肪酸β氧化受损如何影响脂肪酸组成。
将40只C57BL/6小鼠喂食补充有米多君、TTA或米多君与TTA组合的高碳水化合物饮食21天。测定肝脏样本中的脂质水平,并测量肝脏和血浆样本中的脂肪酸组成。此外,评估去饱和酶和延长酶的活性。在肝脏样本中测量参与脂肪酸代谢的酶的肝脏活性和基因表达水平,而在血浆样本中测量肉碱、其前体和酰基肉碱。
血浆中L-肉碱和酰基肉碱水平降低证实了米多君诱导的L-肉碱消耗和线粒体脂肪酸氧化。肝脏脂肪酸组成的主成分分析显示,聚类依赖于米多君和TTA。米多君诱导的肝脏三酰甘油水平升高与延长酶的估计活性呈负相关,并与δ-6去饱和酶(D6D;C18:4n-3/C18:3n-3和C18:3n-6/C18:2n-6)的估计活性升高以及C18:4n-3和C18:3n-6(γ-亚麻酸)的循环水平升高有关。TTA使米多君诱导的三酰甘油水平降低了80%,并减弱了估计中的D6D活性以及n-6多不饱和脂肪酸(PUFA)的延长。TTA还减弱了米多君介导的C24:1n-9(神经酸)的减少,可能是通过刺激芥酸(C22:1n-9)向神经酸的延长和增加。肝脏中神经酸水平和n-6 PUFA延长的估计活性与肝脏三酰甘油水平呈负相关,而D6D的估计活性呈正相关。
γ-亚麻酸的循环水平,以及n-6 PUFA估计延长的减少和D6D去饱和活性的降低,与肝脏三酰甘油水平有关。